,,ii  #aag? ,,congress  #b;d ,session   
,s4 #ceec  ,,9 ,,! ,,s5ate ,,( ,,!      
,,unit$ ,,/ates  ,febru>y #b1 #bjbb,mr4 
,rubio 7= himself & ,mr4 ,coons7        
introduc$ ! foll[+ bill2 :i* 0 read     
twice & ref]r$ to ! ,committee on       
,heal?1 ,education1 ,labor1 & ,p5sions  
,a ,,bill  ,to review dome/ic           
bioph>maceutical manufactur+            
capabilities 9 ord] to improve public   
heal? & m$ical prep>$ness & response    
capabilities & dome/ic bioph>maceutical 
manufactur+ capabilities4  #a4 ,%ort    
title ,?is ,act may be cit$ z ! ,agility
 9 ,manufactur+ ,prep>$ness ,act4  #b4  
,review ( dome/ic bioph>maceutical      
manufactur+ capabilities  7a7 ,9 g5]al  
,! ,secret>y ( ,heal? & ,human ,s]vices 
7ref]r$ to 9 ?is section z ! ,secret>y71
 9 coop]ation ) ! ,director ( !         
,biom$ical ,advanc$ ,rese>* &           
,developm5t ,au?ority1 %all seek to ent]
 into an agreem5t ) ! ,national         
,in/itute = ,innovation 9 ,manufactur+  
,bioph>maceuticals to p]=m ! s]vices    

describ$ 9 subsection 7b74  7b7 ,review 
& recomm5dations ,"u an agreem5t        
describ$ 9 subsection 7a7 betwe5 !      
,secret>y1 ! ,director ( ! ,biom$ical   
,advanc$ ,rese>* & ,developm5t          
,au?ority1 & ! ,national ,in/itute =    
,innovation 9 ,manufactur+              
,bioph>maceuticals1 ! ,national         
,in/itute = ,innovation 9 ,manufactur+  
,bioph>maceuticals %all-- 7#a7 review   
curr5t dome/ic bioph>maceutical         
manufactur+ capacity at ! ,dep>tm5t (   
,heal? & ,human ,s]vices & its          
adaptability to v>i\s ?reats2  7#b7     
draft recomm5dations = develop+1        
demon/rat+1 deploy+1 & advanc+ new      
dome/ic bioph>maceutical manufactur+    
te*nologies t address gaps id5tifi$ "u  
p>agraph 7#a7 & align ,f$]al te*nologies
 ) te*nologies available to ! private   
sector1 includ+ ?r\gh ! new ,bio,m,a,p  
initiative ( ! ,biom$ical ,advanc$      
,rese>* & ,developm5t ,au?ority2 &  7#c7
 id5tify o!r opportunities & priorities 
to improve ! ,unit$ ,/ates public heal? 

& m$ical prep>$ness & response          
capabilities & dome/ic bioph>maceutical 
manufactur+ capabilities4